Latest GLP-1 Therapies Research Papers | Page 14 | OpenScience.ink

4 weeks ago • Diabetes care

New Developments in Diabetes Treatments in AsiaRecent Advances in Diabetes Therapies in Asia.

Article

4 weeks ago • World journal of methodology

Glucagon-like receptor-1 agonists and their link to impotence: A combined analysisGlucagon-like receptor-1 agonists and impotence: A meta-analysis.

Article

4 weeks ago • European journal of internal medicine

Risk of dementia and Parkinson’s disease with GLP-1 receptor drugs compared to other diabetes pills in obese people with type 2 diabetesComparative risks of dementia and Parkinson's disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study.

📖 Top 20% JournalArticle

4 weeks ago • The FEBS journal

Effects of GLP-1 drugs on gut bacteria in type 2 diabetesEffects of GLP-1 agonists on the gut microbiota in type 2 diabetes mellitus: a systematic review.

🥉 Top 5% JournalArticle

4 weeks ago • Current psychiatry reports

Brain effects and possible mental health impacts of GLP-1 and combined GIP/GLP-1 receptor drugs based on systematic evaluationGLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation.

🥉 Top 5% JournalArticle

4 weeks ago • World journal of methodology

Communication between the pancreas and liver, new molecular signals, and potential treatments by 2025Pancreatic-liver crosstalk, novel molecular mediators, and 2025 therapeutic breakthroughs.

Article

4 weeks ago • Inflammatory bowel diseases

GLP-1 receptor agonist treatment is linked to higher symptom remission in ulcerative colitisGLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study.

🎖️ Top 10% JournalArticle

1 month ago • Diabetes research and clinical practice

Effectiveness and safety of different once-weekly diabetes drugs that mimic gut hormonesEfficacy and safety of different once-weekly glucagon-like peptide-1 receptor agonists-A systematic review and Bayesian network meta-analysis.

🎖️ Top 10% JournalSystematic Review

1 month ago • Cureus

Severe Stomach Problems After Restarting Semaglutide at Regular Dose Following a Break During RamadanSevere Gastrointestinal Intolerance After Resuming Maintenance-Dose Semaglutide Following Ramadan-Related Treatment Interruption: A Case Report.

Case Reports

1 month ago • Diabetes research and clinical practice

Use of diabetes medicines and weight-loss surgery in U.S. adults with diabetes and obesity over timeTrends in utilization of glucagon-like peptide‑1 receptor agonists, sodium-glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. Adults with diabetes and obesity.

🎖️ Top 10% JournalArticle

1 month ago • Headache

Glucagon-like peptide-1 receptor agonists and their effects in idiopathic intracranial hypertension: A systematic review and meta-analysisGlucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis.

🎖️ Top 10% JournalArticle

1 month ago • Internal and emergency medicine

Oral semaglutide compared to DPP-4 inhibitors for lowering risk of thinking problems in older adults with heart failure and obesityOral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesity.

Article

1 month ago • Skin appendage disorders

Hair Loss Linked to GLP-1 Receptor Agonists: Review of How Often It Happens, Types, Risks, and Possible CausesGLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms.

📖 Top 50% JournalArticle

1 month ago • Neuromolecular medicine

Semaglutide may reduce inflammation-related memory problems by modifying key cell signaling proteinsSemaglutide Alleviates LPS-Induced Cognitive Disorder via O-GlcNAcylation of AKT-mTOR Signaling Pathway Components.

📖 Top 20% JournalArticle

1 month ago • Surgery

Why patients choose weight-loss surgery even when using diabetes-related medicationsDrugs are not cutting it: Patient motivations for metabolic and bariatric surgery despite glucagon-like peptide-1 use.

Article

1 month ago • JAMA

GLP-1 Gut Hormones: From Discovery to Major Public Health Impact – A Conversation with Jens Juul Holst and Lotte Bjerre KnudsenGLP-1s-From Gut Hormone Discovery to a Public Health Revolution: A Healthy Dialogue With Jens Juul Holst and Lotte Bjerre Knudsen.

Video-Audio Media

1 month ago • Canadian journal of anaesthesia = Journal canadien d'anesthesie

Fasting and leftover stomach contents before endoscopy in patients taking diabetes drugs called GLP-1 receptor agonistsPreoperative fasting status and retained gastric contents in patients undergoing endoscopy who are using glucagon-like peptide type 1 receptor agonists: a multicentre retrospective study.

📖 Top 20% JournalArticle

1 month ago • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Risk scores for kidney disease, irregular heartbeat, and stroke with new diabetes and heart drugs and high other death risksChronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, non-steroidal MRA, and GLP-1 RA, and presence of high competing mortality.

🎖️ Top 10% JournalArticle

1 month ago • Canadian journal of anaesthesia = Journal canadien d'anesthesie

Glucagon-like peptide-1 receptor drugs linked to leftover stomach contents seen during endoscopyGlucagon-like peptide-1 receptor agonists and retained gastric contents on endoscopy: a prospective observational study.

📖 Top 20% JournalArticle

1 month ago • BMJ mental health

Cognitive symptoms in people with mental health diagnoses taking semaglutide: a study of 13,007 patients in the USACognitive signs and symptoms in people with a psychiatric diagnosis on semaglutide: a retrospective cohort study of 13 007 patients in the USA.

🥉 Top 5% JournalArticle

1 month ago • Journal of the American Board of Family Medicine : JABFM

New Uses for GLP-1 Agonists Beyond DiabetesNot Just for Diabetes: The Next Frontier for GLP-1 Agonists.

📖 Top 20% JournalArticle

1 month ago • Journal of molecular endocrinology

Changes in gut structure and hormone-producing cells after stomach surgery in male miceAn analysis of intestinal morphology and incretin-producing cells after sleeve gastrectomy in male mice.

Article

1 month ago • Obesity pillars

Building muscle size and strength while losing weight with incretin-based treatmentIncreasing skeletal muscle mass and strength during incretin-based weight loss.

📖 Top 20% JournalArticle

1 month ago • American journal of physiology. Endocrinology and metabolism

A noninvasive breath test to track delayed digestion caused by semaglutide treatment in miceA noninvasive 13C-mannitol breath test to monitor semaglutide treatment-induced delayed oral-cecal transit in mice.

🎖️ Top 10% JournalArticle

1 month ago • Diabetologia

Dulaglutide versus insulin effects on metabolism and artery disease risk in teenagers with thalassaemia-related diabetesDulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA).

🥈 Top 2% JournalArticle

1 month ago • Frontiers in public health

Quality and trustworthiness of semaglutide health information on Chinese short-video apps Bilibili and TikTokQuality and reliability of semaglutide-related health information on Chinese short-video platforms: a cross-sectional study of Bilibili and TikTok.

📖 Top 20% JournalArticle

← prevpage 14 of 14next →